New Study Found Hydroxychloroquine Lowered COVID-19 Deaths
July 6, 2020
A study published in the International Journal of Infectious Diseases by Henry Ford Health System found that...
hydroxychloroquine
Hydroxycloroquine in COVID-19 Trial Restarted in UK
June 30, 2020
The British Medicines and Healthcare Products Regulatory Agency has approved the restart of a global trial that will explore whether...
Three Healthcare Organizations Issue Statement on FDA Action to End Emergency Authorization of Medications to Treat COVID-19
June 24, 2020
Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on...
FDA Revoked Emergency Use Approval of Hydroxychloroquine for COVID-19
June 15, 2020
The U.S. Food and Drug Administration announced June 15 that it revoked approval called emergency use authorization...
COVID-19 Caused Hydroxychloroquine Issues for Third of Lupus Patients, New LRA Survey Finds
NEW YORK, NY, May 28, 2020. More than one third of people with lupus experienced significant issues filling their...
Lupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET
Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine...
Lupus Research Alliance Thanks FDA for Responsiveness Re Letter Citing Plaquenil Shortages
May 7, 2020
The Lupus Research Alliance held an informative call with the Food and Drug Administration (FDA) in response...
New Data Points Away from Hydroxychloroquine as COVID-19 Treatment
Updated April 23, 2020
The most commonly prescribed treatment for lupus, hydroxychloroquine (best known as Plaquenil) is not effective for...
LRA Proudly Shares First Results from the COVID-19 Global Rheumatology Alliance Registry
April 20,2020
The Lupus Research Alliance is proud to share that the COVID-19 Global Rheumatology Alliance, of which the organization...
Lupus Therapeutics, Affiliate of Lupus Research Alliance, Developing a Study Focused on Lupus Patients and COVID-19
New York, NY, April 7, 2020 – Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance (LRA),...
LRA Urges Congress to Ensure Lupus Patients Maintain Access to Hydroxychloroquine
April 3, 2020
The President and CEO of the LRA, Kenneth Farber wrote personally to Speaker Nancy Pelosi and Leader...
The U.S. Department of Health and Human Services Accepts Donations of Hydroxychloroquine as Possible Treatments for COVID-19 Patients
March 31, 2020
A statement issued March 29 by the U.S. Department of Health and Human Services (HHS) announced that...